Evidence map›Paper›PMID 26184168›Full record

ArticleInternational journal of molecular sciences2015

Impaired Focal Adhesion Kinase-Grb2 Interaction during Elevated Activity in Hippocampal Neurons.

Sachiko Murase

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Sachiko MuraseLaboratory of Molecular Biology, National Institute of Neurological Disorder and Stroke, National Institutes of Health, Bethesda, MD 20892, USA. smurase@umd.edu.
National Institute of Neurological Disorders and Stroke · US

Funding

Intramural NIH HHS
6 · The paper itself

Abstract

Excitatory/inhibitory imbalances are implicated in many neurological disorders. Previously, we showed that chronically elevated network activity induces vulnerability in neurons due to loss of signal transducer and activator of transcription 3 (STAT3) signaling in response to the impairment of the serine/threonine kinase, extracellular-signal-regulated kinases 1/2 (Erk1/2) activation. However, how phosphorylation of Erk1/2 decreases during elevated neuronal activity was unknown. Here I show the pErk1/2 decrease induced by 4-aminopyridine (4-AP), an A-type potassium channel inhibitor can be blocked by a broad-spectrum matrix-metalloproteinase (MMP) inhibitor, FN-439. Surface expression levels of integrin β1 dramatically decrease when neurons are challenged by chronically elevated activity, which is reversed by FN-439. Treatment with 4-AP induces degradation of focal adhesion kinase (FAK), the mediator of integrin signaling. As a result, interactions between FAK and growth factor receptor-bound protein 2 (Grb2), the adaptor protein that mediates Erk1/2 activation by integrin, are severely impaired. Together, these data suggest the loss of integrin signaling during elevated activity causes vulnerability in neurons.

Indexed as

AnimalsCells, CulturedFocal Adhesion Protein-Tyrosine KinasesGRB2 Adaptor ProteinHippocampusHydroxamic AcidsIntegrin beta1Mitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3NeuronsOligopeptidesPhosphorylationRatsRats, Sprague-DawleySignal TransductionSTAT3 Transcription Factor4-aminobenzoyl-glycyl-prolyl-leucyl-alanine hydroxamic acidFocal Adhesion Protein-Tyrosine KinasesGRB2 Adaptor ProteinHydroxamic AcidsIntegrin beta1Mitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3OligopeptidesSTAT3 Transcription FactorErk1/2excitatory/inhibitory (E/I) balancefocal adhesion kinase (FAK)Grb2integrin β1matrix-metalloproteinase (MMP)signal transducer and activator of transcription 3 (STAT3)survival signaling

Identifiers

PMID26184168
PMCPMC4519918
OpenAlexW1542806627

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.